Shanghai Hile Bio-Technology Co., Ltd. (603718.SS)
CNY 7.94
(6.43%)
CNY 7.94
(6.43%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 482.95 Million CNY | 19.77% |
| 2022 | 403.24 Million CNY | -52.94% |
| 2021 | 856.9 Million CNY | 3.92% |
| 2020 | 824.54 Million CNY | 16.34% |
| 2019 | 708.71 Million CNY | -1.95% |
| 2018 | 722.81 Million CNY | 37.2% |
| 2017 | 526.83 Million CNY | 11.02% |
| 2016 | 474.54 Million CNY | 71.31% |
| 2015 | 277 Million CNY | 188.62% |
| 2014 | 95.97 Million CNY | -4.19% |
| 2013 | 100.17 Million CNY | 7.97% |
| 2012 | 92.77 Million CNY | -5.61% |
| 2011 | 98.29 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 398.04 Million CNY | 1.03% |
| 2024 Q1 | 464.46 Million CNY | -3.83% |
| 2024 Q2 | 393.99 Million CNY | -15.17% |
| 2023 Q3 | 430.69 Million CNY | -0.36% |
| 2023 Q2 | 432.25 Million CNY | 19.64% |
| 2023 FY | 482.95 Million CNY | 19.77% |
| 2023 Q4 | 482.95 Million CNY | 12.14% |
| 2023 Q1 | 361.3 Million CNY | -10.4% |
| 2022 Q4 | 403.24 Million CNY | -57.53% |
| 2022 Q3 | 949.56 Million CNY | 2.81% |
| 2022 Q1 | 822.86 Million CNY | -3.97% |
| 2022 FY | 403.24 Million CNY | -52.94% |
| 2022 Q2 | 923.65 Million CNY | 12.25% |
| 2021 Q2 | 800.3 Million CNY | -4.05% |
| 2021 Q4 | 856.9 Million CNY | 4.75% |
| 2021 FY | 856.9 Million CNY | 3.92% |
| 2021 Q1 | 834.05 Million CNY | 1.15% |
| 2021 Q3 | 818.06 Million CNY | 2.22% |
| 2020 Q1 | 696.49 Million CNY | -1.72% |
| 2020 Q2 | 651.56 Million CNY | -6.45% |
| 2020 Q4 | 824.54 Million CNY | 20.61% |
| 2020 FY | 824.54 Million CNY | 16.34% |
| 2020 Q3 | 683.63 Million CNY | 4.92% |
| 2019 Q3 | 803.29 Million CNY | 9.11% |
| 2019 FY | 708.71 Million CNY | -1.95% |
| 2019 Q4 | 708.71 Million CNY | -11.77% |
| 2019 Q1 | 723.94 Million CNY | 0.16% |
| 2019 Q2 | 736.23 Million CNY | 1.7% |
| 2018 Q1 | 537.38 Million CNY | 2.0% |
| 2018 FY | 722.81 Million CNY | 37.2% |
| 2018 Q4 | 722.81 Million CNY | 2.52% |
| 2018 Q3 | 705.02 Million CNY | -5.87% |
| 2018 Q2 | 748.99 Million CNY | 39.38% |
| 2017 Q4 | 526.83 Million CNY | -1.21% |
| 2017 FY | 526.83 Million CNY | 11.02% |
| 2017 Q1 | 640.55 Million CNY | 34.98% |
| 2017 Q2 | 496.18 Million CNY | -22.54% |
| 2017 Q3 | 533.29 Million CNY | 7.48% |
| 2016 Q4 | 474.54 Million CNY | 2.25% |
| 2016 Q2 | 396.25 Million CNY | 17.82% |
| 2016 Q1 | 336.32 Million CNY | 21.41% |
| 2016 Q3 | 464.09 Million CNY | 17.12% |
| 2016 FY | 474.54 Million CNY | 71.31% |
| 2015 Q3 | 191.89 Million CNY | 73.4% |
| 2015 Q1 | 208.78 Million CNY | 117.53% |
| 2015 FY | 277 Million CNY | 188.62% |
| 2015 Q4 | 277 Million CNY | 44.36% |
| 2015 Q2 | 110.66 Million CNY | -47.0% |
| 2014 FY | 95.97 Million CNY | -4.19% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | 95.97 Million CNY | 0.0% |
| 2013 FY | 100.17 Million CNY | 7.97% |
| 2012 FY | 92.77 Million CNY | -5.61% |
| 2011 FY | 98.29 Million CNY | 0.0% |